TreeWAS – Variant ID: rs76137255

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
S52.00 Fracture of upper end of ulna (closed)	0.070	0.930
S52.0 Fracture of upper end of ulna	0.062	0.938
S22 Fracture of rib(s), sternum and thoracic spine	0.061	0.939
S20-S29 Injuries to the thorax	0.061	0.939
S22.4 Multiple fractures of ribs	0.060	0.940
S22.40 Multiple fractures of ribs (closed)	0.060	0.940
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.059	0.941
T36-T50 Poisoning by drugs, medicaments and biological substances	0.059	0.941
S50-S59 Injuries to the elbow and forearm	0.056	0.944
S52 Fracture of forearm	0.055	0.945
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.054	0.946
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.053	0.947
S20 Superficial injury of thorax	0.053	0.947
S22.3 Fracture of rib	0.052	0.948
S27 Injury of other and unspecified intrathoracic organs	0.049	0.951
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.049	0.951
S10-S19 Injuries to the neck	0.048	0.952
S52.01 Fracture of upper end of ulna (open)	0.047	0.952
S90-S99 Injuries to the ankle and foot	0.047	0.953
S22.2 Fracture of sternum	0.047	0.953
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.047	0.953
T39.0 Salicylates	0.047	0.953
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.047	0.953
T20-T25 Burns and corrosions of external body surface, specified by site	0.046	0.954
T39.1 4-Aminophenol derivatives	0.046	0.954
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.046	0.954
T92 Sequelae of injuries of upper limb	0.046	0.954
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.046	0.954
T36 Poisoning by systemic antibiotics	0.045	0.955
S22.30 Fracture of rib (closed)	0.045	0.955
Y52 Agents primarily affecting the cardiovascular system	0.045	0.955
T90 Sequelae of injuries of head	0.045	0.955
S20.8 Superficial injuries of other and unspecified parts of thorax	0.045	0.955
T15-T19 Effects of foreign body entering through natural orifice	0.045	0.955
T46 Poisoning by agents primarily affecting the cardiovascular system	0.045	0.955
T91 Sequelae of injuries of neck and trunk	0.044	0.956
S22.9 Fracture of bony thorax, part unspecified	0.044	0.956
S22.8 Fracture of other parts of bony thorax	0.044	0.956
S22.5 Flail chest	0.044	0.956
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.044	0.956
S26 Injury of heart	0.044	0.956
S25 Injury of blood vessels of thorax	0.044	0.956
S24 Injury of nerves and spinal cord at thorax level	0.044	0.956
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.044	0.956
S21 Open wound of thorax	0.044	0.956
S00-S09 Injuries to the head	0.044	0.956
T00-T07 Injuries involving multiple body regions	0.044	0.956
S70-S79 Injuries to the hip and thigh	0.044	0.956
S22.0 Fracture of thoracic vertebra	0.044	0.956
Y51 Drugs primarily affecting the autonomic nervous system	0.044	0.956
S22.41 Multiple fractures of ribs (open)	0.043	0.957
S22.1 Multiple fractures of thoracic spine	0.043	0.957
Y52.3 Coronary vasodilators, not elsewhere classified	0.043	0.957
T33-T35 Frostbite	0.043	0.957
T26-T28 Burns and corrosions confined to eye and internal organs	0.043	0.957
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.042	0.958
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.042	0.958
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.042	0.958
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.042	0.958
T41 Poisoning by anaesthetics and therapeutic gases	0.042	0.958
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.042	0.958
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.042	0.958
S56 Injury of muscle and tendon at forearm level	0.042	0.958
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.042	0.958
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.042	0.958
S20.2 Contusion of thorax	0.042	0.958
T40.2 Other opioids	0.041	0.958
T42.4 Benzodiazepines	0.041	0.958
S50 Superficial injury of forearm	0.041	0.959
S29 Other and unspecified injuries of thorax	0.041	0.959
S40-S49 Injuries to the shoulder and upper arm	0.041	0.959
S59 Other and unspecified injuries of forearm	0.040	0.960
S58 Traumatic amputation of forearm	0.040	0.960
S57 Crushing injury of forearm	0.040	0.960
S55 Injury of blood vessels at forearm level	0.040	0.960
S54 Injury of nerves at forearm level	0.040	0.960
S53 Dislocation, sprain and strain of joints and ligaments of elbow	0.040	0.960
Chapter XX External causes of morbidity and mortality	0.040	0.960
S52.9 Fracture of forearm, part unspecified	0.040	0.960
S52.7 Multiple fractures of forearm	0.040	0.960
S52.4 Fracture of shafts of both ulna and radius	0.040	0.960
S52.3 Fracture of shaft of radius	0.040	0.960
S52.2 Fracture of shaft of ulna	0.040	0.960
T92.2 Sequelae of fracture at wrist and hand level	0.040	0.960
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.040	0.960
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.040	0.960
T43.5 Other and unspecified antipsychotics and neuroleptics	0.039	0.960
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.039	0.961
S06 Intracranial injury	0.039	0.961
T98 Sequelae of other and unspecified effects of external causes	0.039	0.961
T95 Sequelae of burns, corrosions and frostbite	0.039	0.961
T94 Sequelae of injuries involving multiple and unspecified body regions	0.039	0.961
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.039	0.961
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.039	0.961
S27.2 Traumatic heamopneumothorax	0.039	0.961
Y52.4 Angiotensin-converting-enzyme inhibitors	0.039	0.961
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.039	0.961
T79-T79 Certain early complications of trauma	0.039	0.961
S91 Open wound of ankle and foot	0.039	0.961
S02 Fracture of skull and facial bones	0.038	0.961
S96 Injury of muscle and tendon at ankle and foot level	0.038	0.962
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.038	0.962
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.038	0.962
T39.4 Antirheumatics, not elsewhere classified	0.038	0.962
T39.2 Pyrazolone derivatives	0.038	0.962
Y57 Other and unspecified drugs and medicaments	0.038	0.962
T93 Sequelae of injuries of lower limb	0.038	0.962
S20.7 Multiple superficial injuries of thorax	0.038	0.962
S20.4 Other superficial injuries of back wall of thorax	0.038	0.962
S20.3 Other superficial injuries of front wall of thorax	0.038	0.962
S20.1 Other and unspecified superficial injuries of breast	0.038	0.962
S20.0 Contusion of breast	0.038	0.962
S02.40 Fracture of malar and maxillary bones (closed)	0.038	0.962
S02.4 Fracture of malar and maxillary bones	0.038	0.962
S27.3 Other injuries of lung	0.037	0.962
S22.31 Fracture of rib (open)	0.037	0.962
T43.2 Other and unspecified antidepressants	0.037	0.963
T90.4 Sequelae of injury of eye and orbit	0.037	0.963
J18.9 Pneumonia, unspecified	0.037	0.963
S52.8 Fracture of other parts of forearm	0.037	0.963
S14 Injury of nerves and spinal cord at neck level	0.037	0.963
T45.0 Antiallergic and antiemetic drugs	0.037	0.963
Y48 Anaesthetics and therapeutic gases	0.037	0.963
T20 Burn and corrosion of head and neck	0.037	0.963
S22.20 Fracture of sternum (closed)	0.037	0.963
S52.1 Fracture of upper end of radius	0.037	0.963
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.037	0.963
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.037	0.963
S13 Dislocation, sprain and strain of joints and ligaments at neck level	0.036	0.963
E05 Thyrotoxicosis [hyperthyroidism]	0.036	0.964
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.036	0.964
E05.9 Thyrotoxicosis, unspecified	0.036	0.964
W00-W19 Falls	0.036	0.964
T36.0 Penicillins	0.036	0.964
S19 Other and unspecified injuries of neck	0.035	0.964
T40.4 Other synthetic narcotics	0.035	0.965
E10.9 Without complications	0.035	0.965
Y49 Psychotropic drugs, not elsewhere classified	0.035	0.965
S27.9 Injury of unspecified intrathoracic organ	0.035	0.965
S27.8 Injury of other specified intrathoracic organs	0.035	0.965
S27.7 Multiple injuries of intrathoracic organs	0.035	0.965
S27.6 Injury of pleura	0.035	0.965
S27.5 Injury of thoracic trachea	0.035	0.965
S27.4 Injury of bronchus	0.035	0.965
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.035	0.965
T40.8 Lysergide [LSD]	0.035	0.965
T40.7 Cannabis (derivatives)	0.035	0.965
T40.6 Other and unspecified narcotics	0.035	0.965
T40.5 Cocaine	0.035	0.965
T40.3 Methadone	0.035	0.965
T40.1 Heroin	0.035	0.965
T40.0 Opium	0.035	0.965
T91.2 Sequelae of other fracture of thorax and pelvis	0.035	0.965
T91.3 Sequelae of injury of spinal cord	0.035	0.965
S27.1 Traumatic haemothorax	0.035	0.965
E10 Insulin-dependent diabetes mellitus	0.035	0.965
Y41 Other systemic anti-infectives and antiparasitics	0.035	0.965
S12 Fracture of neck	0.035	0.965
T46.4 Angiotensin-converting-enzyme inhibitors	0.034	0.965
X60-X84 Intentional self-harm	0.035	0.965
S99 Other and unspecified injuries of ankle and foot	0.034	0.965
Chapter IV Endocrine, nutritional and metabolic diseases	0.035	0.965
Y52.1 Calcium-channel blockers	0.034	0.965
S17 Crushing injury of neck	0.034	0.966
S15 Injury of blood vessels at neck level	0.034	0.966
S11 Open wound of neck	0.034	0.966
S10 Superficial injury of neck	0.034	0.966
S18 Traumatic amputation at neck level	0.034	0.966
S16 Injury of muscle and tendon at neck level	0.034	0.966
S72 Fracture of femur	0.034	0.966
T66-T78 Other and unspecified effects of external causes	0.034	0.966
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.034	0.966
S98 Traumatic amputation of ankle and foot	0.034	0.966
S97 Crushing injury of ankle and foot	0.034	0.966
S95 Injury of blood vessels at ankle and foot level	0.034	0.966
S94 Injury of nerves at ankle and foot level	0.034	0.966
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.034	0.966
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.034	0.966
S32 Fracture of lumbar spine and pelvis	0.034	0.966
T17 Foreign body in respiratory tract	0.034	0.966
S27.0 Traumatic pneumothorax	0.034	0.966
S22.21 Fracture of sternum (open)	0.034	0.966
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.034	0.966
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.034	0.966
T42.5 Mixed antiepileptics, not elsewhere classified	0.034	0.966
T42.3 Barbiturates	0.034	0.966
T42.2 Succinimides and oxazolidinediones	0.034	0.966
T42.1 Iminostilbenes	0.034	0.966
T42.0 Hydantoin derivatives	0.034	0.966
T43.9 Psychotropic drug, unspecified	0.034	0.966
T43.8 Other psychotropic drugs, not elsewhere classified	0.034	0.966
T43.6 Psychostimulants with abuse potential	0.034	0.966
T43.4 Butyrophenone and thioxanthene neuroleptics	0.034	0.966
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.034	0.966
S90 Superficial injury of ankle and foot	0.034	0.966
S80-S89 Injuries to the knee and lower leg	0.034	0.966
E05.0 Thyrotoxicosis with diffuse goitre	0.034	0.966
E10-E14 Diabetes mellitus	0.034	0.966
E00-E07 Disorders of thyroid gland	0.034	0.966
T43.3 Phenothiazine antipsychotics and neuroleptics	0.034	0.966
S73 Dislocation, sprain and strain of joint and ligaments of hip	0.033	0.967
T25 Burn and corrosion of ankle and foot	0.033	0.967
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.033	0.967
T23 Burn and corrosion of wrist and hand	0.033	0.967
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.033	0.967
T21 Burn and corrosion of trunk	0.033	0.967
T45.9 Primarily systemic and haematological agent, unspecified	0.033	0.967
T45.8 Other primarily systemic and haematological agents	0.033	0.967
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.033	0.967
T45.6 Fibrinolysis-affecting drugs	0.033	0.967
T45.5 Anticoagulants	0.033	0.967
T45.4 Iron and its compounds	0.033	0.967
T45.3 Enzymes, not elsewhere classified	0.033	0.967
T45.2 Vitamins, not elsewhere classified	0.033	0.967
T45.1 Antineoplastic and immunosuppressive drugs	0.033	0.967
T90.9 Sequelae of unspecified injury of head	0.033	0.967
T92.8 Sequelae of other specified injuries of upper limb	0.033	0.967
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.033	0.967
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.033	0.967
T92.4 Sequelae of injury of nerve of upper limb	0.033	0.967
T92.0 Sequelae of open wound of upper limb	0.033	0.967
Y59 Other and unspecified vaccines and biological substances	0.033	0.967
Y58 Bacterial vaccines	0.033	0.967
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.033	0.967
Y53 Agents primarily affecting the gastro-intestinal system	0.033	0.967
Y50 Central nervous system stimulants, not elsewhere classified	0.033	0.967
Y47 Sedatives, hypnotics and antianxiety drugs	0.033	0.967
Y46 Antiepileptics and anti-Parkinsonism drugs	0.033	0.967
T92.9 Sequelae of unspecified injury of upper limb	0.033	0.967
Y57.9 Drug or medicament, unspecified	0.033	0.967
T90.2 Sequelae of fracture of skull and facial bones	0.033	0.967
T02 Fractures involving multiple body regions	0.033	0.967
T18 Foreign body in alimentary tract	0.033	0.967
T36.9 Systemic antibiotic, unspecified	0.033	0.967
T36.8 Other systemic antibiotics	0.033	0.967
T36.7 Antifungal antibiotics, systemically used	0.033	0.967
T36.6 Rifamycins	0.033	0.967
T36.5 Aminoglycosides	0.033	0.967
T36.4 Tetracyclines	0.033	0.967
T36.3 Macrolides	0.033	0.967
T36.2 Chloramphenicol group	0.033	0.967
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.033	0.967
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.033	0.967
Y52.8 Antivaricose drugs, including sclerosing agents	0.033	0.967
Y52.7 Peripheral vasodilators	0.033	0.967
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.033	0.967
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.033	0.967
W06 Fall involving bed	0.033	0.967
S31 Open wound of abdomen, lower back and pelvis	0.032	0.967
T90.8 Sequelae of other specified injuries of head	0.032	0.968
T90.5 Sequelae of intracranial injury	0.032	0.968
T90.3 Sequelae of injury of cranial nerves	0.032	0.968
T90.1 Sequelae of open wound of head	0.032	0.968
T90.0 Sequelae of superficial injury of head	0.032	0.968
T19 Foreign body in genito-urinary tract	0.032	0.968
T15 Foreign body on external eye	0.032	0.968
T16 Foreign body in ear	0.032	0.968
S49 Other and unspecified injuries of shoulder and upper arm	0.032	0.968
B37.0 Candidal stomatitis	0.032	0.968
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.032	0.968
T46.8 Antivaricose drugs, including sclerosing agents	0.032	0.968
T46.7 Peripheral vasodilators	0.032	0.968
T46.5 Other antihypertensive drugs, not elsewhere classified	0.032	0.968
T46.3 Coronary vasodilators, not elsewhere classified	0.032	0.968
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.032	0.968
T46.1 Calcium-channel blockers	0.032	0.968
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.032	0.968
S56.1 Injury of flexor muscle and tendon of other finger(s) at forearm level	0.032	0.968
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.032	0.968
Y44 Agents primarily affecting blood constituents	0.032	0.968
T93.1 Sequelae of fracture of femur	0.032	0.968
V98-V99 Other and unspecified transport accidents	0.032	0.968
V10-V19 Pedal cyclist injured in transport accident	0.032	0.968
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.032	0.968
T91.9 Sequelae of unspecified injury of neck and trunk	0.032	0.968
T91.8 Sequelae of other specified injuries of neck and trunk	0.032	0.968
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.032	0.968
T91.4 Sequelae of injury of intrathoracic organs	0.032	0.968
T91.1 Sequelae of fracture of spine	0.032	0.968
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.032	0.968
Q38-Q45 Other congenital malformations of the digestive system	0.032	0.968
E20-E35 Disorders of other endocrine glands	0.032	0.968
S06.6 Traumatic subarachnoid haemorrhage	0.032	0.968
S22.51 Flail chest (open)	0.032	0.968
S22.50 Flail chest (closed)	0.032	0.968
S22.81 Fracture of other parts of bony thorax (open)	0.032	0.968
S22.80 Fracture of other parts of bony thorax (closed)	0.032	0.968
S22.91 Fracture of bony thorax, part unspecified (open)	0.032	0.968
S22.90 Fracture of bony thorax, part unspecified (closed)	0.032	0.968
# Top node	0.032	0.968
S21.9 Open wound of thorax, part unspecified	0.032	0.968
S21.8 Open wound of other parts of thorax	0.032	0.968
S21.7 Multiple open wounds of thoracic wall	0.032	0.968
S21.2 Open wound of back wall of thorax	0.032	0.968
S21.1 Open wound of front wall of thorax	0.032	0.968
S21.0 Open wound of breast	0.032	0.968
S23.5 Sprain and strain of other and unspecified parts of thorax	0.032	0.968
S23.4 Sprain and strain of ribs and sternum	0.032	0.968
S23.3 Sprain and strain of thoracic spine	0.032	0.968
S23.2 Dislocation of other and unspecified parts of thorax	0.032	0.968
S23.1 Dislocation of thoracic vertebra	0.032	0.968
S23.0 Traumatic rupture of thoracic intervertebral disk	0.032	0.968
S24.6 Injury of unspecified nerve of thorax	0.032	0.968
S24.5 Injury of other nerves of thorax	0.032	0.968
S24.4 Injury of thoracic sympathetic nerves	0.032	0.968
S24.3 Injury of peripheral nerves of thorax	0.032	0.968
S24.2 Injury of nerve root of thoracic spine	0.032	0.968
S24.1 Other and unspecified injuries of thoracic spinal cord	0.032	0.968
S24.0 Concussion and oedema of thoracic spinal cord	0.032	0.968
S25.9 Injury of unspecified blood vessel of thorax	0.032	0.968
S25.8 Injury of other blood vessels of thorax	0.032	0.968
S25.7 Injury of multiple blood vessels of thorax	0.032	0.968
S25.5 Injury of intercostal blood vessels	0.032	0.968
S25.4 Injury of pulmonary blood vessels	0.032	0.968
S25.3 Injury of innominate or subclavian vein	0.032	0.968
S25.2 Injury of superior vena cava	0.032	0.968
S25.1 Injury of innominate or subclavian artery	0.032	0.968
S25.0 Injury of thoracic aorta	0.032	0.968
S26.9 Injury of heart, unspecified	0.032	0.968
S26.8 Other injuries of heart	0.032	0.968
S26.0 Injury of heart with haemopericardium	0.032	0.968
S28.1 Traumatic amputation of part of thorax	0.032	0.968
S28.0 Crushed chest	0.032	0.968
S08 Traumatic amputation of part of head	0.032	0.968
S07 Crushing injury of head	0.032	0.968
S04 Injury of cranial nerves	0.032	0.968
S03 Dislocation, sprain and strain of joints and ligaments of head	0.032	0.968
S96.1 Injury of muscle and tendon of long extensor muscle of toe at ankle and foot level	0.032	0.968
T06 Other injuries involving multiple body regions, not elsewhere classified	0.031	0.968
T05 Traumatic amputations involving multiple body regions	0.031	0.968
T04 Crushing injuries involving multiple body regions	0.031	0.968
T03 Dislocations, sprains and strains involving multiple body regions	0.031	0.968
T01 Open wounds involving multiple body regions	0.031	0.968
T00 Superficial injuries involving multiple body regions	0.031	0.968
T07 Unspecified multiple injuries	0.031	0.968
S78 Traumatic amputation of hip and thigh	0.032	0.968
S77 Crushing injury of hip and thigh	0.032	0.968
S76 Injury of muscle and tendon at hip and thigh level	0.032	0.968
S75 Injury of blood vessels at hip and thigh level	0.032	0.968
S74 Injury of nerves at hip and thigh level	0.032	0.968
S71 Open wound of hip and thigh	0.032	0.968
S22.01 Fracture of thoracic vertebra (open)	0.031	0.968
J18 Pneumonia, organism unspecified	0.032	0.968
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.031	0.968
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.031	0.968
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.031	0.968
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.031	0.968
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.031	0.968
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.031	0.968
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.031	0.968
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.031	0.968
Y51.1 Other parasympathomimetics [cholinergics]	0.031	0.968
Y51.0 Anticholinesterase agents	0.031	0.968
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.031	0.969
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.031	0.969
S22.11 Multiple fractures of thoracic spine (open)	0.031	0.969
S51 Open wound of forearm	0.031	0.969
S50.9 Superficial injury of forearm, unspecified	0.031	0.969
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.031	0.969
S22.00 Fracture of thoracic vertebra (closed)	0.031	0.969
F31 Bipolar affective disorder	0.031	0.969
T28 Burn and corrosion of other internal organs	0.031	0.969
T27 Burn and corrosion of respiratory tract	0.031	0.969
T26 Burn and corrosion confined to eye and adnexa	0.031	0.969
T35 Frostbite involving multiple body regions and unspecified frostbite	0.031	0.969
T34 Frostbite with tissue necrosis	0.031	0.969
T33 Superficial frostbite	0.031	0.969
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.030	0.969
T37.8 Other specified systemic anti-infectives and antiparasitics	0.030	0.969
T37.5 Antiviral drugs	0.030	0.969
T37.4 Anthelminthics	0.030	0.969
T37.3 Other antiprotozoal drugs	0.030	0.969
T37.2 Antimalarials and drugs acting on other blood protozoa	0.030	0.969
T37.1 Antimycobacterial drugs	0.030	0.969
T37.0 Sulphonamides	0.030	0.969
T38.9 Other and unspecified hormone antagonists	0.030	0.969
T38.8 Other and unspecified hormones and their synthetic substitutes	0.030	0.969
T38.7 Androgens and anabolic congeners	0.030	0.969
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.030	0.969
T38.5 Other oestrogens and progestogens	0.030	0.969
T38.4 Oral contraceptives	0.030	0.969
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.030	0.969
T38.2 Antithyroid drugs	0.030	0.969
T38.1 Thyroid hormones and substitutes	0.030	0.969
T38.0 Glucocorticoids and synthetic analogues	0.030	0.969
T41.5 Therapeutic gases	0.030	0.969
T41.4 Anaesthetic, unspecified	0.030	0.969
T41.3 Local anaesthetics	0.030	0.969
T41.2 Other and unspecified general anaesthetics	0.030	0.969
T41.1 Intravenous anaesthetics	0.030	0.969
T41.0 Inhaled anaesthetics	0.030	0.969
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.030	0.969
T47.8 Other agents primarily affecting the gastro-intestinal system	0.030	0.969
T47.7 Emetics	0.030	0.969
T47.6 Antidiarrhoeal drugs	0.030	0.969
T47.5 Digestants	0.030	0.969
T47.4 Other laxatives	0.030	0.969
T47.3 Saline and osmotic laxatives	0.030	0.969
T47.2 Stimulant laxatives	0.030	0.969
T47.1 Other antacids and anti-gastric-secretion drugs	0.030	0.969
T47.0 Histamine H(2)-receptor antagonists	0.030	0.969
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.030	0.969
T48.6 Antiasthmatics, not elsewhere classified	0.030	0.969
T48.5 Anti-common-cold drugs	0.030	0.969
T48.4 Expectorants	0.030	0.969
T48.3 Antitussives	0.030	0.969
T48.2 Other and unspecified agents primarily acting on muscles	0.030	0.969
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.030	0.969
T48.0 Oxytocic drugs	0.030	0.969
T49.9 Topical agent, unspecified	0.030	0.969
T49.8 Other topical agents	0.030	0.969
T49.7 Dental drugs, topically applied	0.030	0.969
T49.6 Otorhinolaryngological drugs and preparations	0.030	0.969
T49.5 Ophthalmological drugs and preparations	0.030	0.969
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.030	0.969
T49.3 Emollients, demulcents and protectants	0.030	0.969
T49.2 Local astringents and local detergents	0.030	0.969
T49.1 Antipruritics	0.030	0.969
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.030	0.969
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.031	0.969
Y48.3 Local anaesthetics	0.031	0.969
F30-F39 Mood [affective] disorders	0.031	0.969
S91.1 Open wound of toe(s) without damage to nail	0.030	0.969
S56.2 Injury of other flexor muscle and tendon at forearm level	0.030	0.969
S56.8 Injury of other and unspecified muscles and tendons at forearm level	0.030	0.969
S56.7 Injury of multiple muscles and tendons at forearm level	0.030	0.969
S56.5 Injury of other extensor muscle and tendon at forearm level	0.030	0.969
S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level	0.030	0.969
S56.3 Injury of extensor or abductor muscles and tendons of thumb at forearm level	0.030	0.969
S56.0 Injury of flexor muscle and tendon of thumb at forearm level	0.030	0.969
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.030	0.970
T58 Toxic effect of carbon monoxide	0.030	0.970
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.030	0.970
S37 Injury of urinary and pelvic organs	0.030	0.970
S36 Injury of intra-abdominal organs	0.030	0.970
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.030	0.970
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.030	0.970
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.030	0.970
T50.8 Diagnostic agents	0.030	0.970
T50.7 Analeptics and opioid receptor antagonists	0.030	0.970
T50.6 Antidotes and chelating agents, not elsewhere classified	0.030	0.970
T50.5 Appetite depressants	0.030	0.970
T50.4 Drugs affecting uric acid metabolism	0.030	0.970
T50.3 Electrolytic, caloric and water-balance agents	0.030	0.970
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.030	0.970
T50.1 Loop [high-ceiling] diuretics	0.030	0.970
T50.0 Mineralocorticoids and their antagonists	0.030	0.970
S06.9 Intracranial injury, unspecified	0.030	0.970
W06.0 Home	0.030	0.970
S79 Other and unspecified injuries of hip and thigh	0.030	0.970
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.030	0.970
S41 Open wound of shoulder and upper arm	0.030	0.970
T20.0 Burn of unspecified degree of head and neck	0.030	0.970
S91.3 Open wound of other parts of foot	0.030	0.970
Q60-Q64 Congenital malformations of the urinary system	0.030	0.970
S22.10 Multiple fractures of thoracic spine (closed)	0.030	0.970
S06.2 Diffuse brain injury	0.030	0.970
S05 Injury of eye and orbit	0.030	0.970
S50.8 Other superficial injuries of forearm	0.030	0.970
S50.7 Multiple superficial injuries of forearm	0.030	0.970
S50.1 Contusion of other and unspecified parts of forearm	0.030	0.970
S50.0 Contusion of elbow	0.030	0.970
S29.8 Other specified injuries of thorax	0.030	0.970
S29.7 Multiple injuries of thorax	0.030	0.970
S29.0 Injury of muscle and tendon at thorax level	0.030	0.970
S06.5 Traumatic subdural haemorrhage	0.030	0.970
T50.9 Other and unspecified drugs, medicaments and biological substances	0.030	0.970
Q38 Other congenital malformations of tongue, mouth and pharynx	0.030	0.970
W50-W64 Exposure to animate mechanical forces	0.030	0.970
T92.1 Sequelae of fracture of arm	0.030	0.970
X20-X29 Contact with venomous animals and plants	0.030	0.970
S48 Traumatic amputation of shoulder and upper arm	0.030	0.970
S46 Injury of muscle and tendon at shoulder and upper arm level	0.030	0.970
S45 Injury of blood vessels at shoulder and upper arm level	0.030	0.970
S44 Injury of nerves at shoulder and upper arm level	0.030	0.970
S47 Crushing injury of shoulder and upper arm	0.030	0.970
S06.3 Focal brain injury	0.030	0.970
S40 Superficial injury of shoulder and upper arm	0.029	0.970
S27.30 Other injuries of lung (without open wound into thoracic cavity)	0.029	0.970
X58-X59 Accidental exposure to other and unspecified factors	0.029	0.971
S92 Fracture of foot, except ankle	0.029	0.971
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.029	0.971
S13.6 Sprain and strain of joints and ligaments of other and unspecified parts of neck	0.029	0.971
S06.8 Other intracranial injuries	0.029	0.971
S14.1 Other and unspecified injuries of cervical spinal cord	0.029	0.971
S53.1 Dislocation of elbow, unspecified	0.029	0.971
S53.4 Sprain and strain of elbow	0.029	0.971
S53.3 Traumatic rupture of ulnar collateral ligament	0.029	0.971
S53.2 Traumatic rupture of radial collateral ligament	0.029	0.971
S53.0 Dislocation of radial head	0.029	0.971
S54.2 Injury of radial nerve at forearm level	0.029	0.971
S54.9 Injury of unspecified nerve at forearm level	0.029	0.971
S54.8 Injury of other nerves at forearm level	0.029	0.971
S54.7 Injury of multiple nerves at forearm level	0.029	0.971
S54.3 Injury of cutaneous sensory nerve at forearm level	0.029	0.971
S54.1 Injury of median nerve at forearm level	0.029	0.971
S54.0 Injury of ulnar nerve at forearm level	0.029	0.971
S55.9 Injury of unspecified blood vessel at forearm level	0.029	0.971
S55.8 Injury of other blood vessels at forearm level	0.029	0.971
S55.7 Injury of multiple blood vessels at forearm level	0.029	0.971

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations